Market Overview

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)

141.45 +0.81 (0.58%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/15/20B of A SecuritiesMaintainsBuy157.0
9/08/20CitigroupInitiates Coverage OnBuy170.0
8/11/20OppenheimerDowngradesPerform156.0
8/07/20Morgan StanleyMaintainsOverweight197.0
8/07/20SVB LeerinkMaintainsMarket Perform90.0
7/15/20Morgan StanleyMaintainsOverweight199.0
5/28/20UBSMaintainsNeutral122.0
5/13/20RBC CapitalInitiates Coverage OnSector Perform150.0
5/07/20BMO CapitalMaintainsOutperform171.0
5/07/20BarclaysMaintainsOverweight156.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter